NEW YORK (GenomeWeb News) – Illumina reported after the close of the market on Tuesday that its first-quarter revenues increased 36 percent year over year. Based on the strength of its first-quarter results, the firm upped its revenue guidance for full-year 2009 to a range of $700 million to $720 million.

Illumina generated revenues of $165.8 million for the three-month period ended March 29, compared to revenues of $121.9 million for the first quarter of 2008.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

The Wall Street Journal looks into the cost of new gene therapies.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.